about
Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategiesOpportunities and challenges of whole-genome and -exome sequencing.Evidence used in model-based economic evaluations for evaluating pharmacogenetic and pharmacogenomic tests: a systematic review protocol.The role of ADME pharmacogenomics in early clinical trials: perspective of the Industry Pharmacogenomics Working Group (I-PWG).Does lymphopenia or macrocytosis reflect 6-thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine?
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Pharmacogenetics of inflammatory bowel disease.
@en
type
label
Pharmacogenetics of inflammatory bowel disease.
@en
prefLabel
Pharmacogenetics of inflammatory bowel disease.
@en
P2860
P356
P1433
P1476
Pharmacogenetics of inflammatory bowel disease.
@en
P2093
Konstantinos A Papadakis
Konstantinos H Katsanos
P2860
P304
P356
10.2217/PGS.14.154
P577
2014-12-01T00:00:00Z